endogenous glp 1 production Glucagon-like peptide in health and disease Glucagon-like peptide-1 receptor: mechanisms and

Upton, F

Another study in a mouse model of stroke showed that administration of SB 290157 trifluoroacetic acid, a selective complement inhibitor, prevented microglia from engulfing stressed neurons and improved neuroinflammation and cognitive function, indicating the potential effectiveness of complement system inhibitors in preventing and treating cognitive impairments (Surugiu et al., 2019)

A 2023 study in Thyroid found that patients initiating GLP-1 agonists while on stable levothyroxine doses required TSH re-checks at 6 to 8 weeks, with approximately 15% needing a dose increase

No trials have shown a meaningful drop in free T4 when levothyroxine and Ozempic are co-administered, but scheduling is still important